Unsaturated fatty acids and their immunomodulatory properties
S Coniglio, M Shumskaya, E Vassiliou - Biology, 2023 - mdpi.com
Simple Summary Diet can influence human health in both positive and negative ways. Ω-3
polyunsaturated fatty acids have an overall positive effect on humans. The sources of these …
polyunsaturated fatty acids have an overall positive effect on humans. The sources of these …
[HTML][HTML] Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
S Nazir, V Jankowski, G Bender, S Zewinger… - Advanced Drug Delivery …, 2020 - Elsevier
High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially
contributes to the reverse cholesterol transport pathway. Over recent years it has become …
contributes to the reverse cholesterol transport pathway. Over recent years it has become …
[HTML][HTML] COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
AV Sorokin, SK Karathanasis, ZH Yang… - The FASEB …, 2020 - ncbi.nlm.nih.gov
The current coronavirus disease 2019 (COVID‐19) pandemic presents a global challenge
for managing acutely ill patients and complications from viral infection. Systemic …
for managing acutely ill patients and complications from viral infection. Systemic …
Omega-3 fatty acids and metabolic partitioning of fatty acids within the liver in the context of nonalcoholic fatty liver disease
PC Calder - Current Opinion in Clinical Nutrition & Metabolic Care, 2022 - journals.lww.com
Omega-3 fatty acids and metabolic partitioning of fatty acid... : Current Opinion in Clinical
Nutrition & Metabolic Care Omega-3 fatty acids and metabolic partitioning of fatty acids within …
Nutrition & Metabolic Care Omega-3 fatty acids and metabolic partitioning of fatty acids within …
Hypertriglyceridemia: new approaches in management and treatment
The clinical management of HTG is important in the prevention and treatment of acute
pancreatitis and also impacts on how ASCVD risk is managed. More work needs to be done …
pancreatitis and also impacts on how ASCVD risk is managed. More work needs to be done …
A critical review of icosapent ethyl in cardiovascular risk reduction
J Huston, H Schaffner, A Cox, A Sperry… - American Journal of …, 2023 - Springer
Icosapent ethyl (IPE) was the first fish oil product the US Food and Drug Administration
(FDA) approved to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in …
(FDA) approved to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in …
Dietary strategies to improve cardiovascular health: focus on increasing high-density lipoprotein functionality
JT Stadler, G Marsche - Frontiers in Nutrition, 2021 - frontiersin.org
Cardiovascular disease is one of the leading causes of morbidity and mortality worldwide,
with increasing incidence. A cornerstone of cardiovascular disease prevention is lifestyle …
with increasing incidence. A cornerstone of cardiovascular disease prevention is lifestyle …
[HTML][HTML] In vitro gastrointestinal digestibility and lipid oxidation of fish oil-in-water emulsions: Influence of different EPA/DHA ratios
J Zheng, S Chen, L Liu, Q Hu, Y Zhang, Y Zhang, J Wu… - LWT, 2024 - Elsevier
The long-chain omega-3 polyunsaturated fatty acids (ω-3 PUFAs) eicosatetraenoic acid
(EPA) and docosahexaenoic acid (DHA) are known to play roles in supporting human …
(EPA) and docosahexaenoic acid (DHA) are known to play roles in supporting human …
Omega-3 PUFA responders and non-responders and the prevention of lipid dysmetabolism and related diseases
S Serini, G Calviello - Nutrients, 2020 - mdpi.com
The long-chain omega-3 polyunsaturated fatty acids (LC-omega-3 PUFAs)
eicosapentaenoic acid and docosahexaenoic acid are the most popular dietary …
eicosapentaenoic acid and docosahexaenoic acid are the most popular dietary …
Identification of genes regulated by lipids from seaweed Susabinori (Pyropia yezoensis) involved in the improvement of hepatic steatosis: Insights from RNA-Seq …
Hepatic steatosis is an early stage in the progression of non-alcoholic fatty liver disease
(NAFLD) and can lead to the development of non-alcoholic steatohepatitis (NASH), a major …
(NAFLD) and can lead to the development of non-alcoholic steatohepatitis (NASH), a major …